The 2nd Chronic Kidney Disease Summit - Summary Report attempted to capture the essential features of the presentations and workshops.
The pathway ahead to implement the conclusions of the Summit is being determined in the near future.
Chronic Kidney Disease is a national health problem which needs a direct national public health response, not a watered down program that exists in the current system and does not address the issues surrounding CKD adequately. Preventative strategies for kidney disease had been identified and proven effective, but are not in place in Australia.
The aim of this conference was to reassess where Australia is positioned with regard to the prevention, early detection, and best management of chronic kidney disease (CKD) and kidney failure and in particular to examine ways in which the kidney sector might work more effectively with Government.
This Summary Report supports views presented by Summit speakers who alerted Government to budget risk!
The Australian CKD scene is characterized by a steady increase in the numbers of people entering dialysis programs and in those dying of kidney failure. Almost 1 million hospitalizations for dialysis occurred in 2007-8 accounting for 17.4% of all separations from public hospitals. This number had increased by 131% over the last 5 years (AIHW June 2009). The number of people with silent or asymptomatic early CKD was believed to be on the increase driven by the increased prevalence of diabetes and the ageing of the population.
Senior nephrologists, kidney sector health professionals, General Practitioners and representatives from Commonwealth and State Government's health departments addressed the full spectrum of kidney disease from early detection to end stage kidney failure and will bring together some of the world's leading CKD experts with experience in developing public health policies and delivery systems.
The main elements identified for a successful CKD program:
- The need for CKD publicity campaigns aimed at increasing the communities awareness of CKD and its adverse impact on health
- An emphasis on the need for programs targeting high risk groups for early detection
- Best care plans for those in high risk groups
- All CKD programs should be established and pursued in a collaborative fashion with diabetes and cardiovascular disease in recognition of the strong clinical overlap
- The need to emphasize the prominence of CKD as an independent and strong cardiovascular risk factor
- An understanding that the task of early detection and management of detected cases was one for primary care and that only a small proportion of those with CKD needed to be referred for specialist care
- The essential need for a national surveillance program to monitor the incidence and prevalence of CKD (in all its stages) over time.
Click on links below to view individual interviews from key speakers at the CKD Summit or select from playlist icons above on KidneyHealthAus YouTube profile.
|
|
Professor Allan Collins, USA Text version of interview
Director of the KEEP Co-ordinating Center, Allan manages all data resulting from the NKF's KEEP screening programs nationwide and is an expert in CKD clinical and economic outcomes in the USA. He is Immediate Past President, National Kidney Foundation USA - Professor of Medicine, University of Minnesota School of Medicine - Hennepin County Medical Center, Minneapolis - Director of the Chronic Disease Research Group of the Minneapolis Medical Research Foundation - Principal Investigator for the U.S. Renal Data System (USRDS) Co-ordinating Center of National Institutes of Health (NIH).
|
|
|
Professor Adeera Levin, Canada Text version Professor Levin's report
Tale of many functions; Funding, Kidney Services and outcomes
(per video link up) The British Columbia Provisional Renal Agency Canada
Adeera is Co-Chair of the National Kidney Foundation's Kidney Disease Outcomes Quality Initiative (K/DOQI) - President, Canadian Society of Nephrology (2000-2002) - Clinical Professor of Medicine, Division of Nephrology, University of British Columbia - Director of Clinical Research and Education for Nephrology - Director of the Postgraduate Fellowship Program in Nephrology.
|
|
|
Dr Donal O'Donoghue, UK Text of interview
*Chair of National Health Service Framework for Renal Services *Leader of the Policy Team and Implementation Strategy for Kidney Services in England
Dr O'Donoghue's work with the National Service Framework for the National Health Service (NHS) for Renal Services in the United Kingdom has included aligning kidney policy with public health and vascular risk reduction programs, early detection schemes, integrated care and development of a chronic disease management model of care for advanced kidney disease.
|
|
|
Mr David Parker - see YouTube interview
Chair, Kidney Health Australia's National Consumer Council
David suffered from CKD from birth and started on dialysis in 2005 and he received a transplant in 2008. David is involved with seven different boards and advisory committees nationally and in the ACT working on organ donation, renal service delivery and public health and consumer advocacy. His interview covers dialysis from a patient's perspective and the need for Government to act in relation to the ageing population. |
|
|
Ms Anne Wilson - see YouTube interview
Chief Executive Officer of Kidney Health Australia
Latest research which shows Chronic Kidney Disease (CKD) acts as a multiplier for heart, stroke and diabetes. This has seen the US Congress commit $100 billion (25%) of its Medicare budget to fight CKD with a national strategy, including a pilot program of CKD detection by targeted screening and community awareness programs, to limit the expansion of a runaway massive dialysis debt.
At the end of 2007 a total of 9,642 people in Australia were receiving dialysis treatment with the health budget on dialysis blowing out at a million dollars a week.
|
Important Supporting References to the CKD Summit Report 2009
Other useful Australian data souces
Other important statistical references
Australia
International
Australian State CKD Renal Health Networks
The 2nd Australian CKD Summit 2009 was generously supported by:
- Platinum sponsor: Amgen Australia Pty Ltd
- Corporate sponsors: Genzyme Australia Pty Ltd, Janssen-Cilag Pty Ltd and Roche Pty Ltd
- Company sponsor: Baxter Healthcare Pty Ltd
The 1st International CKD Summit 2007 was generously supported by:
- Roche Products Pty Ltd